Medicare Enrolled

Dr. Raul Portillo, MD

Hematology & Oncology · San Antonio, TX
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
1200 BROOKLYN AVE STE 115, San Antonio, TX 78212
2102246531
In practice since 2006 (19 years)
NPI: 1265473391 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Portillo from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Portillo? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Portillo

Dr. Raul Portillo is a hematology & oncology specialist in San Antonio, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Portillo performed 19,394 Medicare services across 1,241 unique beneficiaries.

Between the years covered by Open Payments, Dr. Portillo received a total of $6,020 from 57 pharmaceutical and/or device companies across 251 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Portillo is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 33% volume in TX $6,020 industry payments

Medicare Practice Summary

Medicare Utilization ↗
19,394
Medicare services
Top 33% in TX for hematology & oncology
1,241
Unique beneficiaries
$6
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~1,021 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Iron sucrose injection (Venofer) 7,400 $0 $2
Anti-nausea injection (fosaprepitant) 4,800 $0 $5
Contrast dye for imaging (iodine-based) 3,173 $0 $3
Dexamethasone injection (steroid) 574 $0 $1
Anti-nausea injection (Aloxi/palonosetron) 470 $1 $114
Blood draw (venipuncture) 428 $8 $20
Complete blood count (CBC) with differential 406 $8 $36
Office visit, established patient (20-29 min) 387 $61 $250
Comprehensive metabolic blood panel 331 $10 $64
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less 122 $21 $157
Hospital follow-up visit, moderate complexity 112 $59 $247
Administration of chemotherapy into vein, 1 hour or less 92 $97 $707
Lactate dehydrogenase (enzyme) level 77 $6 $31
Drug injection, under skin or into muscle 64 $11 $96
Ferritin level test (iron stores) 62 $13 $60
Iron level test 62 $6 $27
Iron binding capacity test 62 $8 $35
Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session 62 $272 $2,762
Immunoglobulin level test 51 $9 $56
Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 11-19 mev 51 $178 $700
Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 50 $20 $128
Administration of additional new drug or substance into vein, 1 hour or less 50 $47 $344
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less 49 $46 $313
Office visit, established patient (10-19 min) 43 $41 $150
Microscopic examination for white blood cells with manual cell count 38 $4 $22
Complete blood count (CBC), automated 38 $6 $34
CT scan of abdomen and pelvis with contrast 36 $167 $1,067
Ct scan of chest with contrast 35 $44 $821
Injection, diphenhydramine hcl, up to 50 mg 31 $1 $7
Reticulated (young) platelet measurement 30 $35 $143
Administration of chemotherapy into vein, each additional hour 30 $21 $161
Infusion, normal saline solution , 1000 cc 26 $2 $19
Vitamin B-12 level test 19 $14 $76
Initial hospital admission, moderate complexity 19 $90 $470
Folic acid level test 18 $14 $73
New patient office visit (45-59 min) 16 $101 $565
Carcinoembryonic antigen (cea) protein level 15 $19 $99
Nuclear medicine study from skull base to mid-thigh with ct scan 14 $1,109 $4,802
New patient office visit, complex (60-74 min) 14 $168 $709
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries 14 $91 $657
CT scan of chest, without contrast 12 $49 $686
Office visit, established patient (30-39 min) 11 $89 $368
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.0% high complexity
86.5% medium
12.5% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$6,020
Total received (2018-2024)
Avg $860/year across 7 years
Top 40% in TX for hematology & oncology
57
Companies
251
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,713 (94.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$307 (5.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$733
2023
$897
2022
$399
2021
$343
2020
$731
2019
$1,628
2018
$1,289

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
E.R. Squibb & Sons, L.L.C.
$562
Novartis Pharmaceuticals Corporation
$470
Amgen Inc.
$467
Takeda Pharmaceuticals U.S.A., Inc.
$403
Janssen Biotech, Inc.
$362
GENZYME CORPORATION
$339
PFIZER INC.
$273
Gilead Sciences, Inc.
$263
AstraZeneca Pharmaceuticals LP
$232
Rigel Pharmaceuticals, Inc.
$224
Merck Sharp & Dohme LLC
$204
Exelixis Inc.
$177
Genentech USA, Inc.
$141
Merck Sharp & Dohme Corporation
$129
Lilly USA, LLC
$127
Genmab U.S., Inc.
$125
ImmunoGen, Inc.
$125
Stemline Therapeutics Inc.
$110
Incyte Corporation
$109
Verastem, Inc.
$89
Bayer HealthCare Pharmaceuticals Inc.
$76
EMD Serono, Inc.
$66
Astellas Pharma US Inc
$61
Daiichi Sankyo Inc.
$59
Celgene Corporation
$59
Puma Biotechnology, Inc.
$58
Alexion Pharmaceuticals, Inc.
$44
Teva Pharmaceuticals USA, Inc.
$42
EISAI INC.
$42
AbbVie, Inc.
$40
Eisai Inc.
$36
Kite Pharma, Inc.
$29
Seagen Inc.
$29
Pharmacyclics LLC, An AbbVie Company
$29
Clovis Oncology, Inc.
$29
Dendreon Pharmaceuticals LLC
$26
Apellis Pharmaceuticals, Inc.
$26
Blueprint Medicines Corporation
$22
Advanced Accelerator Applications
$21
ABBVIE INC.
$21
Medtronic USA, Inc.
$20
Array BioPharma Inc.
$20
TESARO, Inc.
$19
BeiGene USA, Inc.
$19
Alnylam Pharmaceuticals Inc.
$19
R-Pharm US LLC
$17
MACROGENICS, INC.
$17
Regeneron Healthcare Solutions, Inc.
$17
GlaxoSmithKline, LLC.
$17
Myriad Genetic Laboratories, Inc.
$16
Ipsen Biopharmaceuticals, Inc
$15
Karyopharm Therapeutics Inc.
$15
APO-PHARMA USA, INC.
$14
Seattle Genetics, Inc.
$13
Kyowa Kirin, Inc.
$13
Dova Pharmaceuticals
$12
Global Blood Therapeutics, Inc.
$12
Top 3 companies account for 24.9% of total payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · ALIMTA · ALUNBRIG · AYVAKIT · BENDEKA · BLENREP · BRACANALYSIS CDX · BRUKINSA · Bavencio · Braftovi · CABLIVI · CALQUENCE · CREON · CYRAMZA · Cabometyx · Copiktra · DARZALEX · DEFERIPRONE · Doptelet · ELIQUIS · ELITEK · EMEND · EMPLICITI · ERBITUX · ERLEADA · EVENITY · Elahere · Enhertu · Epkinly · Erleada · FRUZAQLA · GAZYVA · GIVLAARI · Halaven · IBRANCE · IMBRUVICA · IMFINZI · Imbruvica · Ixempra · JADENU · JAKAFI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · Kyprolis · LIBTAYO · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lutathera · MARGENZA · MEKINIST · MYLOTARG · NERLYNX · NINLARO · Nerlynx · Neulasta · Nplate · Nubeqa · OPDIVO · OSTEOCOOL RF ABLATION · OXBRYTA · Orserdu · PADCEV · PROMACTA · PROVENGE · Pomalyst · Prolia · RYDAPT · Revlimid · Rezlidhia · Rituxan · Rubraca · SANCUSO · SANDOSTATIN LAR · SARCLISA · SCEMBLIX · SUTENT · Stivarga · TAGRISSO · TASIGNA · TUMOR LYSIS SYNDROME - DISEASE · Tavalisse · Trodelvy · ULTOMIRIS · VERZENIO · VOTRIENT · Vectibix · Venclexta · Vitrakvi · XGEVA · XOSPATA · XPOVIO · XTANDI · XYNTHA · Xofigo · Yescarta · ZEJULA · ZYTIGA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (95%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $31 per 100 Medicare services performed
Looking for a hematology & oncology specialist in San Antonio?
Compare hematology & oncology specialists in the San Antonio area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncology specialists nearby

Geographic Context

Hematology & oncology specialists within 10 mi
56
Per 100K population
2.7
County median income
$70,571
Nearest hospital
BAPTIST MEDICAL CENTER
2.8 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Portillo is a mixed practice specialist, with moderate Medicare volume, with low-engagement industry engagement, with 19 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Portillo experienced with iron sucrose injection (venofer)?
Based on Medicare claims data, Dr. Portillo performed 7,400 iron sucrose injection (venofer) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Portillo receive payments from pharmaceutical companies?
Yes. Dr. Portillo received a total of $6,020 from 57 companies across 251 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Portillo's costs compare to other hematology & oncology specialists in San Antonio?
Dr. Portillo's average Medicare payment per service is $6. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Portillo) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →